Pediatric Hodgkin's disease - Up, up, and beyond

International Journal of Radiation Oncology Biology Physics

Volumn 54, Issue 1, 2002, Pages 1-8

  Donaldson, Sarah S ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Pediatric Hodgkin's disease; Prognosis; Treatment

Indexed keywords

ANTIBODIES; CHEMOTHERAPY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; TOXICITY; TRANSPLANTATION (SURGICAL);

RADIOCURABILITY;

ONCOLOGY;

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; METHOTREXATE; PREDNISONE; PROCARBAZINE; RITUXIMAB; VINBLASTINE; VINCRISTINE;

ARTICLE; ATOPY; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; HEART INJURY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK POPULATION; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; LUNG INJURY; LUNG TOXICITY; MULTIMODALITY CANCER THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE;

BONE MARROW TRANSPLANTATION; CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; NEOPLASM STAGING;

EID: 0036719245     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02903-6     Document Type: Article

References (55)

1. Tribute - Juan Angel del Regato, M.D.
2. Tribute - Juan Angel del Regato, M.D.
3. Hodgkin's disease
4. Natural history of Hodgkin's disease as related to staging
5. Combination chemotherapy in the treatment of advanced Hodgkin's disease
6. Radiation induced height impairment in pediatric Hodgkin's disease
7. Childhood Hodgkin's disease in Uganda: A ten year experience
8. Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease
9. Hodgkin's disease in children: A ten-year experience in South Africa
10. Treatment of Hodgkin's disease in children with or without radiotherapy
11. Pediatric Hodgkin's disease: Focus on the future
12. Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease
13. Hodgkin's disease in children: Treatment with MOPP and low-dose, extended field irradiation without laparotomy - Late results and toxicity
14. The intergroup Hodgkin's disease in children: A study of stages I and II
15. Low-dose radiation therapy, and reduced chemotherapy in childhood Hodgkin's disease: The experience of the French Society of Pediatric Oncology
16. Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age: An Italian (AIEOP) multicenter study on 215 patients
17. Treatment of children with Hodgkin's disease - Results of the German Pediatric Oncology Group
18. Treatment of children and adolescents with Hodgkin's disease: The experience of the German-Austrian Paediatric Study Group
19. The effects of different cumulative doses of chemotherapy on testicular function: Results in 75 patients treated for Hodgkin's disease during childhood or adolescence
20. Gonadal toxicity after combination chemotherapy for Hodgkin's disease: Comparative results of MOPP vs ABVD
21. Breast cancer and other second neoplasms after childhood Hodgkin's disease
22. Risk of second cancers after treatment for Hodgkin's disease
23. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP
24. ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: The Stanford experience
25. Pediatric Hodgkin's disease: Pulmonary, cardiac, and thyroid function following combined modality therapy
26. Cardiopulmonary function in long-term survivors of childhood Hodgkin's lymphoma: A pilot study
27. Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease
28. The balance between cure and late effects in childhood Hodgkin's lymphoma: The experience of the German-Austrian Study-Group since 1978. German-Austrian Pediatric Hodgkin's Disease Study Group
29. High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: The German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group
30. Localized childhood Hodgkin's disease: Response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy - Results of the French Society of Pediatric Oncology Study MDH90
31. Treatment of children with unfavorable and advanced stage Hodgkin's disease with vinblastine, etoposide, prednisone, and adriamycin (VEPA) and low-dose, involved field irradiation
32. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: A Pediatric Oncology Group study
33. Radiation in pediatric Hodgkin's disease
34. In reply to editorial: Radiation in pediatric Hodgkin's Disease
35. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy
36. VAMP, and low-dose involved field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: Results of a prospective clinical trial
37. Cancer statistics, 2001
38. Pathology, and genetics of tumours of haematopoietic and lymphoid tissues
39. Pathology of classical Hodgkin's disease
40. A prognostic score for advanced Hodgkin's disease
41. Staging of Hodgkin disease in children: Comparison of CT and lymphography with laparotomy
42. Gallium-67 scans as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin's disease: A Pediatric Oncology Group study
43. A tabulated summary of the FDG PET literature
44. Oncological applications of FDG PET imaging: Brain tumors, colorectal cancer, lymphoma and melanoma
45. 2-(fluorine-18)fluoro-2-deoxy-d-glucose positron emission tomography in the detection and staging of malignant lymphoma: A bicenter trial
46. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease
47. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging
48. Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma
49. 18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin's lymphoma - Comparison with CT
50. Prognostic factors in pediatric Hodgkin's disease
51. Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents
52. Autologous bone marrow transplantation for pediatric Hodgkin's disease: A case-matched comparison with adult patients by the European Bone Marrow Transplant Group Lymphoma Registry
53. High-dose therapy, and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: Atopy predicts idiopathic diffuse lung injury syndromes
54. The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse
55. Rituximab (R) in lymphocyte predominant Hodgkin's disease (LPHD): Results of a phase II trial